VK
Vamsi Krishna Remella
About Vamsi Krishna Remella
Data last updated:
Vamsi Krishna Remella has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Astranix Pharma Solutions Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astranix Pharma Solutions Private Limited at ₹3.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Astranix Pharma Solutions Private Limited U72900TG2020PTC139101 | Director | 10 Feb 2020 | 2020 | ₹3.5 Lakh (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vamsi Krishna Remella
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vamsi Krishna Remella
Vamsi Krishna Remella has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Astranix Pharma Solutions Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Astranix Pharma Solutions Private Limited at ₹3.5 Lakh (FY 2024).
Vamsi Krishna Remella is associated with 1 company as Director, including Astranix Pharma Solutions Private Limited (₹3.5 Lakh).
Vamsi Krishna Remella has expertise in General Business.
Vamsi Krishna Remella has 6 years in corporate governance.
By reported revenue, the largest current company of Vamsi Krishna Remella is Astranix Pharma Solutions Private Limited, with revenue of ₹3.5 Lakh (FY 2024).
Vamsi Krishna Remella currently holds positions at 1 company: Astranix Pharma Solutions Private Limited (₹3.5 Lakh).